IMMUNOCORE HLDGS ADS/1 Cash Flow Quality Index
IMMUNOCORE HLDGS ADS/1 cash flow quality index. IMMUNOCORE HLDGS ADS/1 (6YG) has a Cash Flow Quality Index of -1.06x as of March 2026. Operating cash flow of €-13.78 Million is below net income of €12.97 Million, suggesting accrual-heavy earnings not yet converted to cash. See IMMUNOCORE HLDGS ADS/1 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
IMMUNOCORE HLDGS ADS/1 Cash Flow Quality Index by Year (None–None)
IMMUNOCORE HLDGS ADS/1 cash flow quality index by year from None to None. Year-by-year earnings quality comparison for IMMUNOCORE HLDGS ADS/1. For the full cash flow conversion analysis, see IMMUNOCORE HLDGS ADS/1 (6YG) cash conversion ratio.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|